Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways (Q38738613)
Jump to navigation
Jump to search
scientific article published on 20 August 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways |
scientific article published on 20 August 2016 |
Statements
1 reference
Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways (English)
1 reference
Xi-Jun Zhang
1 reference
Shen-Shan Jia
1 reference
20 August 2016
1 reference
1 reference
83
1 reference
1164-1174
1 reference
Identifiers
1 reference
1 reference